{"id":5944,"date":"2026-01-17T08:35:56","date_gmt":"2026-01-17T16:35:56","guid":{"rendered":"https:\/\/wrwofficial.com\/index.php\/2026\/01\/17\/wegovy-obesity-pill-now-available-at-pharmacies-shots\/"},"modified":"2026-01-17T08:36:02","modified_gmt":"2026-01-17T16:36:02","slug":"wegovy-obesity-pill-now-available-at-pharmacies-shots","status":"publish","type":"post","link":"https:\/\/wrwofficial.com\/index.php\/2026\/01\/17\/wegovy-obesity-pill-now-available-at-pharmacies-shots\/","title":{"rendered":"Wegovy obesity pill now available at pharmacies : Shots"},"content":{"rendered":"

<\/p>\n

\n
\n
\n <\/picture>\n<\/div>\n
\n
\n
\n

\n A pill form of Wegovy, the popular obesity drug previously available only by injection, is now being stocked by pharmacies.
\n <\/p>\n

Novo Nordisk<\/p>\n

<\/b>
\n hide caption<\/b><\/b>\n <\/p>\n<\/p><\/div>\n

toggle caption<\/b><\/b>\n <\/div>\n

<\/p>\n

Novo Nordisk<\/p>\n

<\/span>\n<\/div>\n<\/p><\/div>\n

The Wegovy pill launched Monday, and the starting dose is now available at pharmacies around the country with higher doses arriving by the end of the week.<\/p>\n

<\/p>\n

The Food and Drug Administration approved the pill for obesity on Dec. 22. It’s also approved to reduce the risk of heart attack and stroke in patients who are obese or overweight.<\/p>\n

The pill follows the blockbuster success of Novo Nordisk’s Wegovy injection, which has been on the market since 2021<\/u><\/a> and became so popular that it was in short supply until February 2025<\/u><\/a>.<\/p>\n

The pill version of the drug helped patients lose about as much weight as the injection. In a study published<\/u><\/a> in the New England Journal of Medicine<\/em>, a 25 milligram Wegovy pill led to a 13.6% reduction in weight on average over 64 weeks. Patients taking a placebo in the study lost 2.2% of their weight. For patients who stayed on the treatment, reduced their calorie intake and exercised, Novo Nordisk estimates<\/u><\/a> they would have a 16.6% reduction in their weight.<\/p>\n